Back to Search
JOVIE N. BRIDGEWATER M.D.
M.D.
Anesthesiology Physician
NPI: 1831176973IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
16307(MS)
Education
OTHER
Class of 1982
Research & Publications (20)
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.
PMID 19451431·J Clin Oncol·2009
3-trial
Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer.
PMID 18854549·Ann Oncol·2009
3-trial
Primary tumour resection and survival in the palliative management of metastatic colorectal cancer.
PMID 18644695·Eur J Surg Oncol·2009
4-observational
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study.
PMID 19672264·Br J Cancer·2009
3-trial
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.
PMID 19406901·Ann Oncol·2009
3-trial
A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study).
PMID 18253119·Br J Cancer·2008
3-trial
Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary.
PMID 18414470·Br J Cancer·2008
8-other
Improved sequencing of oxidized cysteine and methionine containing peptides using electron transfer dissociation.
PMID 17583533·J Am Soc Mass Spectrom·2007
8-other
The effect of histidine oxidation on the dissociation patterns of peptide ions.
PMID 17157528·J Am Soc Mass Spectrom·2007
8-other
Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US.
PMID 17265519·Cancer·2007
3-trial
Using metal-catalyzed oxidation reactions and mass spectrometry to identify amino acid residues within 10 A of the metal in Cu-binding proteins.
PMID 16872838·J Am Soc Mass Spectrom·2006
7-preclinical
Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer.
PMID 16311275·Ann Oncol·2006
3-trial
Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors.
PMID 16533784·Clin Cancer Res·2006
3-trial
Transition metal-peptide binding studied by metal-catalyzed oxidation reactions and mass spectrometry.
PMID 16579630·Anal Chem·2006
8-other
Antioxidant mechanisms of enzymatic hydrolysates of beta-lactoglobulin in food lipid dispersions.
PMID 17147447·J Agric Food Chem·2006
8-other
Using microwave-assisted metal-catalyzed oxidation reactions and mass spectrometry to increase the rate at which the copper-binding sites of a protein are determined.
PMID 16013884·Anal Chem·2005
8-other
Statistical mechanical load balancer for the web.
PMID 15903752·Phys Rev E Stat Nonlin Soft Matter Phys·2005
8-other
Metal-catalyzed oxidation reactions and mass spectrometry: the roles of ascorbate and different oxidizing agents in determining Cu-protein-binding sites.
PMID 15866536·Anal Biochem·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7601 SOUTHCREST PKWY
SOUTHAVEN, MS 38671 - Phone
- (662) 349-4000
Quick Facts
- NPI
- 1831176973
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile